The pathway enrichment analysis identified several dysregulated pathways critical to NSCLC progression, including the ATM-dependent DNA damage response, TGF-β signaling, cell cycle regulation, Hippo signaling, and TGF-β-mediated EMT. The gene discussed is TGFB1; the disease is non-small cell lung carcinoma.